Cagrilintide 5mg × 10 vials
Cagrilintide is commonly associated with appetite support, metabolic balance, and body composition-focused routines. A premium addition to advanced weight management peptide catalogs.
Description
Cagrilintide
A long-acting amylin analogue studied for weight management research, appetite regulation, metabolic response, satiety signaling, and glucose-related pathways.
Product Overview
Compound: Cagrilintide
Strength: 5 mg per vial
Injection type: Subcutaneous
Frequency: Research protocol dependent
Reconstitution
Amount in vial: 5 mg
BAC water: 2 mL
Amount per unit: 25 mcg per unit
Research Dose
Protocol dependent.
Notes
Cagrilintide is described in published research as a long-acting amylin analogue. It has been studied in weight management and metabolic research, both as a standalone compound and in combination with semaglutide.
No standard consumer dosing protocol should be assumed. Use only within appropriate research or professional guidance frameworks.
Disclaimer
This product is intended for research and informational purposes only.
Additional information
| Weight | 100 g |
|---|---|
| Dimensions | 10 × 4 × 4 cm |
| Dosage | 5 mg, 10 mg |
Reviews
There are no reviews yet.